Skip to content

Biossil raised $153 million in an undisclosed stage round led by OpenAI Startup Fund, announced Sept. 27.

Facts

Company
Biossil
Amount
$153 million
Currency
USD
Stage
Undisclosed stage
Announced
Sep 27, 2026
Instrument
Equity
Valuation
$1 billion (officially disclosed)

Investors

Use of funds

Expand clinical development capacity and acquire additional drug candidates.

As stated by the company.

Sources

  1. 1.Biossil hits unicorn status with new OpenAI-led financing — BetaKit, Sep 28, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026